Aids Drugs & Patents Laws

Guests: BRENDA WILSON NPR Reporter MICHAEL WALDHOLZ Editor for Health and Science, The Wall Street TOBY KASPER Coordinator of Doctors without Borders, Access to Essential Medicines Campaign GUY MACDONALD Vice President, Anti-Infective Franchise at Merck DR. CHRISTOPHER OUMA National Coordinator for Kenya's Action Aid HIV Program In South Africa, international drug companies are fighting to stop the government there from violating patent laws and making low-cost, generic drugs available to people with AIDS. South Africa is one on many developing countries where the leaders believe the need to address the AIDS crisis supersedes international patent laws. Join Juan Williams and guests for discussion about access to AIDS drugs in the third world and whether or not international trade laws should be observed in the face of a medical crisis.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.